XML 54 R44.htm IDEA: XBRL DOCUMENT v3.6.0.2
Share-based Compensation (Tables)
6 Months Ended
Dec. 31, 2016
Share-based Compensation  
Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense and the weighted average fair value of the options granted

 

 

 

Six Months Ended

 

 

 

December 31, 2016

 

December 31, 2015

 

Risk-free interest rate

 

1.1 

%

1.7 

%

Expected volatility

 

55.6 

%

48.3 

%

Expected dividend yield

 

0.0 

%

0.0 

%

Forfeiture rate

 

6.5 

%

6.5 

%

Expected term (in years)

 

5.2 years

 

5.2 years

 

Weighted average fair value

 

$

15.33 

 

$

26.24 

 

 

Summary of stock option award activity

 

(In thousands, except for weighted average price and life data)

 

Awards

 

Weighted-
Average
Exercise
Price

 

Aggregate
Intrinsic
Value

 

Weighted
Average
Remaining
Contractual
Life (yrs.)

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2016

 

1,730

 

$

16.77

 

$

19,524

 

6.3

 

Granted

 

11

 

$

31.30

 

 

 

 

 

Exercised

 

(190

)

$

6.54

 

$

4,325

 

 

 

Forfeited, expired or repurchased

 

(19

)

$

31.40

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2016

 

1,532

 

$

17.96

 

$

14,370

 

6.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at December 31, 2016

 

1,525

 

$

17.85

 

$

14,370

 

6.2

 

Exercisable at December 31, 2016

 

1,379

 

$

15.64

 

$

14,370

 

6.0

 

 

Summary of nonvested restricted stock awards

 

(In thousands)

 

Awards

 

Weighted
Average Grant -
date Fair Value

 

Aggregate
Intrinsic Value

 

 

 

 

 

 

 

 

 

Non-vested at June 30, 2016

 

167

 

$

48.22

 

 

 

Granted

 

275

 

$

25.03

 

 

 

Vested

 

(76

)

$

43.80

 

$

2,326

 

Forfeited

 

(18

)

$

37.13

 

 

 

 

 

 

 

 

 

 

 

 

Non-vested at December 31, 2016

 

348

 

$

31.38

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

December 31,

 

December 31,

 

(In thousands)

 

2016

 

2015

 

2016

 

2015

 

Selling, general and administrative expenses

 

$

1,251 

 

$

1,494 

 

$

3,223 

 

$

5,380 

 

Research and development expenses

 

152 

 

201 

 

325 

 

389 

 

Cost of sales

 

314 

 

329 

 

625 

 

629 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

1,717 

 

$

2,024 

 

$

4,173 

 

$

6,398 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax benefit at statutory rate

 

$

627 

 

$

729 

 

$

1,523 

 

$

2,303